Migraine Headache and Ischemic Stroke Risk: An Updated Meta-analysis

American Journal of Medicine

Volumn 123, Issue 7, 2010, Pages 612-624

  Spector, June T ^a   Kahn, Susan R ^b   Jones, Miranda R ^a   Jayakumar, Monisha ^a   Dalal, Deepan ^a   Nazarian, Saman ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral ischemia; Epidemiology; Meta analysis; Risk factors; Stroke

Indexed keywords

CHOLESTEROL; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONFOUNDING VARIABLE; DISEASE ASSOCIATION; FAMILY HISTORY; HEART DISEASE; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; META ANALYSIS; MIGRAINE; MIGRAINE WITH AURA; ORAL CONTRACEPTION; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW;

HUMANS; MIGRAINE DISORDERS; ODDS RATIO; RISK FACTORS; STROKE;

EID: 77953703756     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.12.021     Document Type: Article

References (58)

1. Lopez A.D., Mathers C.D., Ezzati M., et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367 (2006) 1747-1757
2. Feigin V.L., Lawes C.M., Bennett D.A., and Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 (2003) 43-53
3. Stewart W.F., Shechter A., and Rasmussen B.K. Migraine prevalence. A review of population-based studies. Neurology 44 (1994) S17-S23
4. Lipton R.B., Bigal M.E., Diamond M., et al., AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68 (2007) 343-349
5. Goldstein L.B., Adams R., Alberts M.J., et al., American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 1583-1633
6. Curtis K.M., Mohllajee A.P., and Peterson H.B. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 73 (2006) 189-194
7. Etminan M., Takkouche B., Isorna F.C., and Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 330 (2005) 63
8. Lloyd-Jones D., Adams R., Carnethon M., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) e21-e181
9. Hall G.C., Brown M.M., Mo J., and MacRae K.D. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 62 (2004) 563-568
10. Kurth T., Slomke M.A., Kase C.S., et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64 (2005) 1020-1026
11. Kurth T., Gaziano J.M., Cook N.R., et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 167 (2007) 795-801
12. Becker C., Brobert G.P., Almqvist P.M., et al. Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache 47 (2007) 1374-1384
13. GS Higgins JPT. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. www.cochrane-handbook.org Accessed March 5, 2009
14. Pavlakis S.G., Phillips P.C., DiMauro S., et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16 (1984) 481-488
15. Dichgans M., Mayer M., Uttner I., et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44 (1998) 731-739
16. Marini C., Carolei A., Roberts R.S., et al. Focal cerebral ischemia in young adults: a collaborative case-control study. Neuroepidemiology 12 (1993) 70-81
17. Schwaag S., Nabavi D.G., Frese A., et al. The association between migraine and juvenile stroke: a case-control study. Headache 43 (2003) 90-95
18. MacClellan L.R., Giles W., Cole J., et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 38 (2007) 2438-2445
19. Naess H., Nyland H.I., Thomassen L., et al. Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control study. Eur J Neurol 11 (2004) 25-30
20. Lidegaard O., and Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception 65 (2002) 197-205
21. Stang P.E., Carson A.P., Rose K.M., et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 64 (2005) 1573-1577
22. Velentgas P., Cole J.A., Mo J., et al. Severe vascular events in migraine patients. Headache 44 (2004) 642-651
23. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000) 2008-2012
24. Hayden J.A., Cote P., and Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144 (2006) 427-437
25. von Elm E., Altman D.G., Egger M., et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147 (2007) 573-577
26. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 Suppl 1 (2004) 9-160
27. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 21 (1990) 637-676
28. Kidwell C.S., and Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke 34 (2003) 2995-2998
29. Collaborative Group. Oral contraceptives and stroke in young women. Associated risk factors. JAMA 231 (1975) 718-722
30. Buring J.E., Hebert P., Romero J., et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 52 (1995) 129-134
31. Carolei A., Marini C., and De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 347 (1996) 1503-1506
32. Chang C.L., Donaghy M., and Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 318 (1999) 13-18
33. Donaghy M., Chang C.L., Poulter N., and European Collaborators of The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatr 73 (2002) 747-750
34. Haapaniemi H., Hillbom M., and Juvela S. Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke 28 (1997) 26-30
35. Henrich J.B., and Horwitz R.I. A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 42 (1989) 773-780
36. Merikangas K.R., Fenton B.T., Cheng S.H., et al. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 54 (1997) 362-368
37. Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynaecol 102 (1995) 153-159
38. Nightingale A.L., and Farmer R.D. Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database. Stroke 35 (2004) 1574-1578
39. Tzourio C., Iglesias S., Hubert J., et al. Migraine and risk of ischaemic stroke: a case control study. BMJ 307 (1993) 289-292
40. Tzourio C., Tehindrazanarivelo A., Iglesias S., et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 310 (1995) 830-833
41. Mosek A., Marom R., Korczyn A.D., and Bornstein N. A history of migraine is not a risk factor to develop an ischemic stroke in the elderly. Headache 41 (2001) 399-401
42. Elliott D. Migraine and stroke: current perspectives. Neurol Res 30 (2008) 801-812
43. D'Andrea G., Hasselmark L., Alecci M., et al. Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura. J Neurol Neurosurg Psychiatry 57 (1994) 557-561
44. Zeller J.A., Frahm K., Baron R., et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke?. J Neurol Neurosurg Psychiatry 75 (2004) 984-987
45. Gallai V., Sarchielli P., Firenze C., et al. Endothelin 1 in migraine and tension-type headache. Acta Neurol Scand 89 (1994) 47-55
46. Tietjen G.E., Al-Qasmi M.M., Athanas K., et al. Increased von Willebrand factor in migraine. Neurology 57 (2001) 334-336
47. Hering-Hanit R., Friedman Z., Schlesinger I., and Ellis M. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 21 (2001) 137-139
48. Scher A.I., Terwindt G.M., Verschuren W.M., et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 59 (2006) 372-375
49. Tanasescu R., Nicolau A., Caraiola S., et al. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases. Rom J Intern Med 45 (2007) 355-363
50. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 (1988) 1148-1152
51. Katsarava Z., Rabe K., and Diener H.C. From migraine to stroke. Intern Emerg Med 3 Suppl 1 (2008) S9-S16
52. Feske S.K. Stroke in pregnancy. Semin Neurol 27 (2007) 442-452
53. Allais G., Gabellari I.C., Mana O., et al. Migraine and stroke: the role of oral contraceptives. Neurol Sci 29 (2008) S12-S14
54. Sare G.M., Gray L.J., and Bath P.M. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 29 (2008) 2031-2041
55. Davis P.H. Use of oral contraceptives and postmenopausal hormone replacement: evidence on risk of stroke. Curr Treat Options Neurol 10 (2008) 468-474
56. Nappi R.E., Sances G., Detaddei S., et al. Hormonal management of migraine at menopause. Menopause Int 15 (2009) 82-86
57. Lay C.L., and Payne R. Recognition and treatment of menstrual migraine. Neurologist 13 (2007) 197-204
58. Pryse-Phillips W.E., Dodick D.W., Edmeads J.G., et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian headache society. CMAJ 156 (1997) 1273-1287